Nuwellis Inc
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The compan… Read more
Nuwellis Inc (NUWE) - Net Assets
Latest net assets as of September 2025: $3.91 Million USD
Based on the latest financial reports, Nuwellis Inc (NUWE) has net assets worth $3.91 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($7.98 Million) and total liabilities ($4.07 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $3.91 Million |
| % of Total Assets | 49.02% |
| Annual Growth Rate | 8.33% |
| 5-Year Change | -59.98% |
| 10-Year Change | -46.35% |
| Growth Volatility | 1078.92 |
Nuwellis Inc - Net Assets Trend (2002–2024)
This chart illustrates how Nuwellis Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Nuwellis Inc (2002–2024)
The table below shows the annual net assets of Nuwellis Inc from 2002 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $6.53 Million | +103.36% |
| 2023-12-31 | $3.21 Million | -74.01% |
| 2022-12-31 | $12.36 Million | -52.38% |
| 2021-12-31 | $25.95 Million | +59.01% |
| 2020-12-31 | $16.32 Million | +720.00% |
| 2019-12-31 | $1.99 Million | -66.48% |
| 2018-12-31 | $5.94 Million | -63.44% |
| 2017-12-31 | $16.24 Million | +824.19% |
| 2016-12-31 | $1.76 Million | -85.56% |
| 2015-12-31 | $12.17 Million | -58.34% |
| 2014-12-31 | $29.21 Million | -43.52% |
| 2013-12-31 | $51.73 Million | +299.47% |
| 2012-12-31 | $12.95 Million | +181.74% |
| 2011-12-31 | $4.60 Million | +14.40% |
| 2010-12-31 | $4.02 Million | 0.00% |
| 2009-12-31 | $4.02 Million | +145.36% |
| 2008-12-31 | $1.64 Million | -82.77% |
| 2007-12-31 | $9.51 Million | +37.95% |
| 2006-12-31 | $6.89 Million | +57.18% |
| 2005-12-31 | $4.38 Million | -39.97% |
| 2004-12-31 | $7.30 Million | +5136.46% |
| 2003-12-31 | $139.47K | -87.57% |
| 2002-12-31 | $1.12 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Nuwellis Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 29675174778.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $468.00K | 7.17% |
| Other Comprehensive Income | $-47.00K | -0.72% |
| Other Components | $304.90 Million | 4669.22% |
| Total Equity | $6.53 Million | 100.00% |
Nuwellis Inc Competitors by Market Cap
The table below lists competitors of Nuwellis Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ALLSTATE
MU:ALS
|
$1.76 Million |
|
Luvu Brands Inc
OTCQB:LUVU
|
$1.77 Million |
|
LBI Capital Bhd
KLSE:8494
|
$1.77 Million |
|
Silver Grail Resources Ltd
PINK:SVGAF
|
$1.77 Million |
|
Lincoln Gold Mining Inc
PINK:LNCLF
|
$1.76 Million |
|
Digital Ally Inc
NASDAQ:DGLY
|
$1.76 Million |
|
J.B.HUNT TRANSP - Dusseldorf Stock Exchang
DU:JB1
|
$1.76 Million |
|
Aeeris Ltd
AU:AER
|
$1.76 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nuwellis Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 3,211,000 to 6,530,000, a change of 3,319,000 (103.4%).
- Net loss of 11,165,000 reduced equity.
- Dividend payments of 541,000 reduced retained earnings.
- New share issuances of 8,428,000 increased equity.
- Other comprehensive income decreased equity by 16,000.
- Other factors increased equity by 6,613,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-11.16 Million | -170.98% |
| Dividends Paid | $541.00K | -8.28% |
| Share Issuances | $8.43 Million | +129.07% |
| Other Comprehensive Income | $-16.00K | -0.25% |
| Other Changes | $6.61 Million | +101.27% |
| Total Change | $- | 103.36% |
Book Value vs Market Value Analysis
This analysis compares Nuwellis Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.01x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | $56113700.00 | $1.08 | x |
| 2003-12-31 | $6973450.00 | $1.08 | x |
| 2004-12-31 | $365161700.00 | $1.08 | x |
| 2005-12-31 | $219191450.00 | $1.08 | x |
| 2006-12-31 | $344518550.00 | $1.08 | x |
| 2007-12-31 | $475258650.00 | $1.08 | x |
| 2008-12-31 | $81869200.00 | $1.08 | x |
| 2009-12-31 | $200872900.00 | $1.08 | x |
| 2010-12-31 | $200872900.00 | $1.08 | x |
| 2011-12-31 | $229800000.00 | $1.08 | x |
| 2012-12-31 | $647450000.00 | $1.08 | x |
| 2013-12-31 | $1034540000.00 | $1.08 | x |
| 2014-12-31 | $584300000.00 | $1.08 | x |
| 2015-12-31 | $243420000.00 | $1.08 | x |
| 2016-12-31 | $25100000.00 | $1.08 | x |
| 2017-12-31 | $231971428.57 | $1.08 | x |
| 2018-12-31 | $59360000.00 | $1.08 | x |
| 2019-12-31 | $1895238.10 | $1.08 | x |
| 2020-12-31 | $877311.83 | $1.08 | x |
| 2021-12-31 | $556802.58 | $1.08 | x |
| 2022-12-31 | $104401.82 | $1.08 | x |
| 2023-12-31 | $2402.89 | $1.08 | x |
| 2024-12-31 | $206.64 | $1.08 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nuwellis Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -170.98%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -127.75%
- • Asset Turnover: 0.89x
- • Equity Multiplier: 1.51x
- Recent ROE (-170.98%) is above the historical average (-267.74%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | -726.59% | -4324.88% | 0.02x | 10.11x | $-1.03 Million |
| 2004 | -52.26% | -999.77% | 0.05x | 1.05x | $-4.55 Million |
| 2005 | -119.09% | -416.61% | 0.26x | 1.08x | $-5.66 Million |
| 2006 | -142.05% | -358.29% | 0.38x | 1.03x | $-10.48 Million |
| 2007 | -98.02% | -2207.60% | 0.04x | 1.02x | $-10.27 Million |
| 2008 | -398.21% | -6020.39% | 0.05x | 1.21x | $-6.68 Million |
| 2009 | -138.20% | -1387.90% | 0.09x | 1.11x | $-5.95 Million |
| 2010 | -138.20% | -1387.90% | 0.09x | 1.11x | $-5.95 Million |
| 2011 | -352.39% | 0.00% | 0.00x | 1.62x | $-16.66 Million |
| 2012 | -108.62% | 0.00% | 0.00x | 1.16x | $-15.36 Million |
| 2013 | -42.06% | -36877.97% | 0.00x | 1.07x | $-26.93 Million |
| 2014 | -87.58% | -8673.56% | 0.01x | 1.11x | $-28.51 Million |
| 2015 | -218.41% | -45055.93% | 0.00x | 2.02x | $-27.80 Million |
| 2016 | -898.80% | -1225.14% | 0.17x | 4.25x | $-15.97 Million |
| 2017 | -82.41% | -376.64% | 0.19x | 1.14x | $-15.01 Million |
| 2018 | -286.93% | -340.78% | 0.57x | 1.48x | $-17.63 Million |
| 2019 | -910.25% | -328.69% | 0.98x | 2.82x | $-18.31 Million |
| 2020 | -97.05% | -212.82% | 0.37x | 1.23x | $-17.47 Million |
| 2021 | -75.36% | -246.86% | 0.26x | 1.17x | $-22.15 Million |
| 2022 | -117.54% | -170.02% | 0.35x | 2.00x | $-15.76 Million |
| 2023 | -629.37% | -227.99% | 0.91x | 3.04x | $-20.53 Million |
| 2024 | -170.98% | -127.75% | 0.89x | 1.51x | $-11.82 Million |
Industry Comparison
This section compares Nuwellis Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nuwellis Inc (NUWE) | $3.91 Million | -726.59% | 1.04x | $1.76 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |